The May 10, 2018, article by Ma et al entitled “Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)” (J Clin Oncol 10.1200/JCO.2017.77.0388) was published with an error.
There should have been an Acknowledgement section included with the following statement: “The study would like to acknowledge the support of the Partner State Key Lab at YK Pao Centre for Cancer and the Hong Kong Cancer Fund.”
This has been corrected as of June 20, 2018. The authors apologize for the error.